Author | Title | Source | Year |
Yao-Chun Hsu, Chih-Cheng Chen, Wei-Hsiang Lee, Chi-Yang Chang, Fu-Jen Lee, Cheng-Hao Tseng, Tzu-Haw Chen, Hsiu J Ho, Jaw-Town Lin, Chun-Ying Wu. | Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents. | Sci Rep. 2022 Mar 31;12(1):5481. doi: 10.1038/s41598-022-09534-w. | 2022 |
Hyun-Seok Kim, Xian Yu, Jennifer Kramer, Aaron P Thrift, Pete Richardson, Yao-Chun Hsu, Avegail Flores, Hashem B El-Serag, Fasiha Kanwal. | Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. | J Hepatol. 2022 Feb;76(2):294-301. doi: 10.1016/j.jhep.2021.09.009. | 2022 |
Yao-Chun Hsu, Vithika Suri, Mindie H Nguyen, Yen-Tsung Huang, Chi-Yi Chen, I-Wei Chang, Cheng-Hao Tseng, Chun-Ying Wu, Jaw-Town Lin, David Z Pan, Anuj Gaggar, Ondrej Podlaha. | Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations with Implications on Host Gene Dysregulation. | Gastroenterology. 2022 Jan 4:S0016-5085(22)00006-3. doi: 10.1053/j.gastro.2021.12.286. | 2022 |
Chi-Cheng Huang, Chih-Yi Liu, Chi-Jung Huang, Yao-Chun Hsu, Heng-Hui Lien, Jia-Uei Wong, Feng-Chuan Tai, Wen-Hui Ku, Chi-Feng Hung, Jaw-Town Lin, Ching-Shui Huang, Han-Sun Chiang. | Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing. | Int J Mol Sci. 2022 Jan 29;23(3):1579. doi: 10.3390/ijms23031579. | 2022 |
Yao-Chun Hsu, Jia-Ling Wu, Mindie H Nguyen. | Reply. | Clin Gastroenterol Hepatol. 2022 Aug;20(8):1886-1887. doi: 10.1016/j.cgh.2021.09.032. | 2022 |
Jiyoon Park, An K Le, Tai-Chung Tseng, et al. | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine. | Clin Gastroenterol Hepatol. 2022 Apr;20(4):874-885.e4. doi: 10.1016/j.cgh.2021.05.062. | 2022 |
Yao-Chun Hsu, Jia-Ling Wu, Cheng-Hao Tseng, Mindie H Nguyen, Chih-Wen Lin, Chih-Lung Hung. | Severe Acute Exacerbation after Cessation of Nucleos(t)ide Analog for Chronic Hepatitis B: a Real-world Study of Routine Practice. | Clin Gastroenterol Hepatol. 2022 Jun;20(6):1413-1415.e3. doi: 10.1016/j.cgh.2021.08.037. | 2022 |
Jennifer R Kramer, Peter A Richardson, Hyunseok Kim, Yao-Chun Hsu, Fasiha Kanwal, Hashem B El-Serag. | The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus. | Clin Gastroenterol Hepatol. 2022 Mar 8:S1542-3565(22)00214-2. doi: 10.1016/j.cgh.2022.02.056. | 2022 |
Chih-Hsun Yi, Ming-Jong Bair, Jen-Hung Wang, Ming-Wun Wong, Tso-Tsai Liu, Wei-Yi Lei, Shu-Wei Liang, Lin Lin, Jui-Sheng Hung, Jee-Fu Huang, Yao-Chun Hsu, Chien-Lin Chen. | Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection. | J Microbiol Immunol Infect. 2022 May 17:S1684-1182(22)00065-2. doi: 10.1016/j.jmii.2022.04.011. | 2022 |
Chen CY, Shun CT, Hu WH, et al. | Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial. | Lancet Gastroenterol Hepatol. 2022 Dec 19:S2468-1253(22)00384-3. doi: 10.1016/S2468-1253(22)00384-3. | 2022 |
Chih-Hsun Yi, Ming-Jong Bair, Jen-Hung Wang, Ming-Wun Wong, Tso-Tsai Liu, Wei-Yi Lei, Shu-Wei Liang, Lin Lin, Jui-Sheng Hung, Jee-Fu Huang, Yao-Chun Hsu, Chien-Lin Chen. | Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection. | J Microbiol Immunol Infect. 2022 Aug;55(4):643-650. doi: 10.1016/j.jmii.2022.04.011. | 2022 |
Xinxing Tantai, Yi Liu, Yee Hui Yeo, et al. | Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. | J Hepatol. 2022 Mar;76(3):588-599. doi: 10.1016/j.jhep.2021.11.006. | 2022 |
Cheng-Hao Tseng, Tzu-Haw Chen, Jia-Ling Wu, Teng-Yu Lee, John A Borghi, Jaw-Town Lin, Mindie H Nguyen, Yao-Chun Hsu. | Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis. | JHEP Rep. 2022 Oct 28;5(1):100617. doi: 10.1016/j.jhepr.2022.100617. | 2022 |
Yao-Chun Hsu, Cheng-Hao Tseng, Mindie H Nguye. | Reply. | Clin Gastroenterol Hepatol. 2022 Aug;20(8):1891-1892. doi: 10.1016/j.cgh.2021.10.026. | 2022 |
Feng-Chen Kao, Yao-Chun Hsu, Tzu-Shan Chen, Yuan-Kun Tu, Pao-Hsin Liu. | Incidence and risk factors of vertebral body collapse after posterior instrumented spinal fusion in elderly patients: An observational study. | Medicine (Baltimore). 2022 Nov 4;101(44):e31604. doi: 10.1097/MD.0000000000031604. | 2022 |
Wang YC, Tsai MC, Chen YS, Hsieh PM, Hung CM, Lin HY, Hsu YC, Yeh JH, Hsiao P, Su YC, Ma CH, Lee CY, Lin CC, Shu CW, Li YC, Tsai MH, Lin JY, Peng WH, Yu ML, Lin CW. | NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression. | Hepatol Commun. 2022 Nov 2. doi: 10.1002/hep4.2019. Epub ahead of print. | 2022 |
Ying Liu, Yunyu Zhao, Xu Gao, Jiashu Liu, Fanpu Ji, Yao-Chun Hsu, Zhengxiao Li, Mindie H Nguyen. | Recognizing skin conditions in patients with cirrhosis: a narrative review. | Ann Med. 2022 Dec;54(1):3017-3029. doi: 10.1080/07853890.2022.2138961. | 2022 |
Hsu YC, Jun DW, Peng CY, et al. | Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort. | Hepatol Int. 2022 Sep 7. doi: 10.1007/s12072-022-10411-x. Epub ahead of print. | 2022 |
Mei-Jyh Chen, Ming-Jong Bair, Po-Yueh Chen, et al. | Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis. | Helicobacter. 2022 Jul 18:e12914. doi: 10.1111/hel.12914. | 2022 |
Choi HSJ, Hirode G, Chen CH, et al. | Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B. | Clin Gastroenterol Hepatol. 2022 Jul 18:S1542-3565(22)00672-3. doi: 10.1016/j.cgh.2022.07.005. | 2022 |
Ming-Chao Tsai, Sien-Sing Yang, Chih-Che Lin, Wen-Lun Wang, Yao-Chun Hsu, Yaw-Sen Chen, Jui-Ting Hu, James Yu Lin, Ming-Lung Yu, Chih-Wen Lin. | Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis. | JAMA Netw Open. 2022 Jul 1;5(7):e2223511. doi: 10.1001/jamanetworkopen. | 2022 |
Yeh ML, Liang PC, Tsai PC, Wang SC, Leong J, Ogawa E, Jun DW, Tseng CH, Landis C, Tanaka Y, Huang CF, Hayashi J, Hsu YC, Huang JF, Dai CY, Chuang WL, Nguyen MH, Yu ML. | Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. | Cancers (Basel). 2021 Jul 9;13(14):3455. doi: 10.3390/cancers13143455. | 2021 |
Hsu YC, Chen CY, Chang IW, Chang CY, Wu CY, Lee TY, Wu MS, Bair MJ, Chen JJ, Chen CC, Tseng CH, Tai CM, Huang YT, Ku WH, Mo LR, Lin JT. | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. | Lancet Infect Dis. 2021 Jun;21(6):823-833. doi: 10.1016/S1473-3099(20)30692-7. Epub 2021 Jan 29. Erratum in: Lancet Infect Dis. 2021 May;21(5):e122. | 2021 |
Feng-Chen Kao, Yao-Chun Hsu, Tzu-Shan Chen, Pao-Hsin Liu, Yuan-Kun Tu. | Combination of long- and short-axis alar sacroplasty techniques under fluoroscopic guidance for osteoporotic sacral insufficiency fracture. | J Orthop Surg Res. 2021 Apr 17;16(1):269. doi: 10.1186/s13018-021-02409-2. | 2021 |
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al | Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. | J Infect Dis. 2021 Dec 1;224(11):1890-1899. doi: 10.1093/infdis/jiab241. | 2021 |
Chen YS, Hsieh PM, Lin HY, Hung CM, Lo GH, Hsu YC, Lu IC, Lee CY, Wu TC, Yeh JH, Hsiao P, Li YC, Wang YC, Hsieh KC, Lin CW. | Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis. | BMC Gastroenterol. 2021 May 14;21(1):220. doi: 10.1186/s12876-021-01807-4. | 2021 |
Park J, Le AK, Tseng TC, et al. | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine. | Clin Gastroenterol Hepatol. 2021 Jun 2:S1542-3565(21)00601-7. doi: 10.1016/j.cgh.2021.05.062. Epub ahead of print. | 2021 |
Yao-Chun Hsu, Yen-Tsung Huang, Jaw-Town Lin. | Fibrosis in patients with chronic hepatitis B and minimally raised ALT during tenofovir therapy - Authors' reply. | Lancet Infect Dis. 2021 Jul;21(7):911. doi: 10.1016/S1473-3099(21)00331-5. | 2021 |
Daw-Shyong Perng, Chao-Ming Hung, Hung-Yu Lin, Paul Morgan, Yao-Chun Hsu, Tsung-Chin Wu, Pei-Min Hsieh, Jen-Hao Yeh, Pojen Hsiao, Chih-Yuan Lee, Yu-Chan Li, Ya-Chin Wang, Yaw-Sen Chen, Chih-Wen Lin. | Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection. | BMC Cancer. 2021 Jul 17;21(1):828. doi: 10.1186/s12885-021-08553-6. | 2021 |
Hwai-I Yan, Yao-Chun Hsu. | Editorial: incorporating liver stiffness to risk scores for HCC in patients with chronic hepatitis B treated with oral antivirals: ready to use or not? | Aliment Pharmacol Ther. 2021 Mar;53(6):753-754. doi: 10.1111/apt.16279. | 2021 |
Hirode G, Choi HS, Chen CH, et al. | Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study). | Gastroenterology. 2021 Nov 8:S0016-5085(21)03723-9. doi: 10.1053/j.gastro.2021.11.002. Epub ahead of print. | 2021 |
Yao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al. | Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. | J Infect Dis. 2021 Dec 1;224(11):1890-1899. doi: 10.1093/infdis/jiab241. | 2021 |
Yao-Chun Hsu, Jia-Ling Wu, Mindie H Nguyen. | Quantify the Risk of Severe Hepatitis B Flare in a Real World Where Cessation of Nucleos(t)ide Analog is Routinely Practiced. | Clin Gastroenterol Hepatol. 2021 Sep 26:S1542-3565(21)01046-6. doi: 10.1016/j.cgh.2021.09.032. Epub ahead of print. | 2021 |
Yao-Chun Hsu, Cheng-Hao Tseng, Yen-Tsung Huang, Hwai-I Yang. | Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective. | Semin Liver Dis. 2021 Aug;41(3):285-297. doi: 10.1055/s-0041-1730924. | 2021 |
Hyun-Seok Kim, Xian Yu, Jennifer Krame, Aaron P Thrift, Pete Richardson, Yao-Chun Hsu, Avegail Flores, Hashem B El-Serag, Fasiha Kanwal. | Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. | J Hepatol. 2021 Sep 23:S0168-8278(21)02039-0. doi: 10.1016/j.jhep.2021.09.009. Epub ahead of print. | 2021 |
Mindie H Nguyen, Masanori Atsukawa, Toru Ishikawa, et al. | Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir. | Am J Gastroenterol. 2021 Jun 1;116(6):1264-1273. doi: 10.14309/ajg.0000000000001157. | 2021 |
Yao-Chun Hsu, Cheng-Hao Tseng, Tung-Hung Su, Jia-Horng Kao, Mindie H Nguyen. | Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. | Gut. 2021 Oct 20:gutjnl-2021-326232. doi: 10.1136/gutjnl-2021-326232. Epub ahead of print. | 2021 |
Yao-Chun Hsu, Cheng-Hao Tseng, Mindie H Nguyen. | Lurking in acute hepatitis B flares following treatment cessation were inescapable uncertainty and potential irreversibility. | Clin Gastroenterol Hepatol. 2021 Oct 19:S1542-3565(21)01139-3. doi: 10.1016/j.cgh.2021.10.026. Epub ahead of print. | 2021 |
Tantai X, Liu Y, Yeo YH, et al. | Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. | J Hepatol. 2021 Nov 13:S0168-8278(21)02174-7. doi: 10.1016/j.jhep.2021.11.006. Epub ahead of print. | 2021 |
Cheng-Hao Tseng, Yao-Chun Hsu, Hsiu J Ho, Mindie H Nguyen, Chun-Ying Wu. | Increasing Age and Nonliver Comorbidities in Patients with Chronic Hepatitis B in Taiwan: A Nationwide Population-Based Analysis. | Dig Dis. 2021;39(3):266-274. doi: 10.1159/000511585. Epub 2020 Sep 15. | 2021 |
Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen. | Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. | Lancet Gastroenterol Hepatol. 2021 Feb;6(2):87-88. doi: 10.1016/S2468-1253(20)30395-2. | 2021 |
Chang WY, Chiu YC, Chiu FW, Hsu YC, Tseng TC, Cheng PN, Yang SS, Liu CJ, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. | High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy. | J Infect Dis. 2020 Sep 14;222(8):1345-1352. doi: 10.1093/infdis/jiaa256. PMID: 32396638. | 2020 |
Tseng CH, Hsu YC, Chen TH, Ji F, Chen IS, Tsai YN, Hai H, Thuy LTT, Hosaka T, Sezaki H, Borghi JA, Cheung R, Enomoto M, Nguyen MH. | Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. | Lancet Gastroenterol Hepatol. 2020 Sep 29:S2468-1253(20)30249-1. doi: 10.1016/S2468-1253(20)30249-1. Epub ahead of print. PMID: 33007228. | 2020 |
Teng-Yu Lee, Yao-Chun Hsu, Hsiao-Ching Tseng, Jaw-Town Lin, Ming-Shiang Wu, Chun-Ying Wu. | Association of Daily Aspirin Therapy with Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis C Virus Infection [published online ahead of print, 2020 Apr 28]. | Clin Gastroenterol Hepatol. 2020;S1542-3565(20)30533-4. doi:10.1016/j.cgh.2020.04.036 | 2020 |
Chao-Ming Tseng, Hsi-Hao Wang, Wen-Lun Wang, Ching-Tai Lee, Chi-Ming Tai, Cheng-Hao Tseng, Chih-Cheng Chen, Ying-Nan Tsai, Meng-Shun Sun, Yao-Chun Hsu | Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer. | Endocr Pract. 2020 Jul;26(7):707-713. doi: 10.4158/EP-2019-0565. Epub 2020 Nov 24. | 2020 |
Chun-Ying Wu, Hsiu J Ho, Chen-Yi Wu, Yi-Ju Chen, Teng-Tu Lee, Yao-Chun Hsu, Jaw-Town Lin. | Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor. | Gut. 2020 Sep 9:gutjnl-2020-321932. doi: 10.1136/gutjnl-2020-321932. Epub ahead of print. PMID: 32907829. | 2020 |
Chih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, Yao-Chun Hsu , Chia-Chang Hsu, Tsung-Chin Wu, Jen-Hao Yeh, Pojen Hsiao, Pei-Min Hsieh, Hung-Yu Lin, Chih-Wen Shu, Chao-Ming Hung. | Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis. | BMC Gastroenterol. 2020;20(1):99. Published 2020 Apr 10. doi:10.1186/s12876-020-01235-w | 2020 |
Feng-Chen Kao, Yao-Chun Hsu, Tzu-Shan Chen, Yuan-Kun Tu, Pao-Hsin Liu. | Effects of Injected Antiosteoporotic Medication Versus Oral Bisphosphonates on Rates of Repeated Vertebroplasty or Kyphoplasty. | Clin Ther. 2020 Jun;42(6):1087-1098.e2. doi: 10.1016/j.clinthera.2020.04.011. Epub 2020 Jun 6. PMID: 32513494. | 2020 |
Yao-Chun Hsu, Mindie H Nguyen. | Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. | Am J Gastroenterol. 2020;115(2):302–303. doi:10.14309/ajg.0000000000000507 | 2020 |
Tzu-Chun Chung, Tzu-Shan Chen, Yao-Chun Hsu, Feng-Chen Kao, Yuan-Kun Tu, Pao-Hsin Liu. | Long-term total hip arthroplasty rates in patients with acetabular and pelvic fractures after surgery: A population-based cohort study. | PLoS One. 2020;15(4):e0231092. Published 2020 Apr 3. doi:10.1371/journal.pone.0231092 | 2020 |
Cheng-Hao Tseng, Mindie H Nguyen, Yao-Chun Hsu. | Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on. | Hepatol Int. 2020 Sep;14(5):886-887. doi: 10.1007/s12072-020-10080-8. Epub 2020 Aug 13. | 2020 |
Yao-Chun Hsu, Yen-Tsung Huang. | Editorial: risk assessment for chronic hepatitis B patients in the immune tolerant phase-both definition and selection matter. | Aliment Pharmacol Ther. 2020 Jul;52(1):213-214. doi: 10.1111/apt.15798. PMID: 32529769. | 2020 |
Cheng-Hao Tseng, Chao-Ming Tseng, Jia-Ling Wu, Yao-Chun Hsu, Hashem B El-Serag. | Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review. | J Gastroenterol Hepatol. 2020 Oct;35(10):1684-1693. doi: 10.1111/jgh.15078. Epub 2020 May 17. PMID: 32343431. | 2020 |
Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen. | Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. | Lancet Gastroenterol Hepatol. 2021 Feb;6(2):87-88. doi: 10.1016/S2468-1253(20)30395-2. | 2020 |
Ogawa E, Toyoda H, Iio E, et al. | Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication. | Clin Infect Dis. 2020 Dec 31;71(11):2840-2848. doi: 10.1093/cid/ciz1160. | 2020 |
Tanaka Y, Ogawa E, Huang CF, et al. | HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort. | Hepatol Int. 2020 Dec;14(6):1023-1033. doi: 10.1007/s12072-020-10105-2. Epub 2020 Dec 4. | 2020 |
Chen VL, Yeh ML, Yang JD, et al. | Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma. | Hepatol Commun. 2020 Sep 24;5(1):122-132. doi: 10.1002/hep4.1606. | 2020 |
Chen CC, Luo JC, Fang YJ, et al. | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial. | Therap Adv Gastroenterol. 2020 Jul 31;13:1756284820927306. doi: 10.1177/1756284820927306. PMID: 32821287; PMCID: PMC7406927. | 2020 |
Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, Wu CY. | Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. | JAMA Intern Med. 2019;179(5):633–640. doi:10.1001/jamainternmed.2018.8342 | 2019 |
Lee TL, Kao FC, Hsu YC, Lo YY, Tu YK. | Perioperative acute myocardial infarction rate in chronic renal disease patients undergoing orthopedic surgery: Is there any difference between dialyzed and nondialyzed patients? | PLoS One. 2019 Jan 17;14(1):e0210554. doi: 10.1371/journal.pone.0210554. eCollection 2019. | 2019 |
Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY. | Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285]. | J Hepatol. 2019 Mar;70(3):581. doi: 10.1016/j.jhep.2018.12.010. Epub 2019 Jan 8. | 2019 |
Hsu YC, Tseng CH, Kao JH. | Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done. | Clin Gastroenterol Hepatol. 2019 Apr;17(5):1000-1001. doi: 10.1016/j.cgh.2018.09.002. | 2019 |
Yao-Chun Hsu4, Mindie H Nguyen, Lein-Ray Mo, Ming-Shiang Wu, Tzeng-Huey Yang, Chieh-Chang Chen, Cheng-Hao Tseng, Chi-Ming Tai, Chun-Ying Wu, Jaw-Town Lin, Yasuhito Tanaka, Chi-Yang Chang. | Combining Hepatitis B Core-Related and Surface Antigens at End of Nucleos(t)ide Analogue Treatment to Predict Off-Therapy Relapse Risk | Aliment Pharmacol Ther. 2019;49(1):107–115. doi:10.1111/apt.15058 | 2019 |
Hsu YC, Yip TC, Wong GL, Wu CY. | Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues". | J Hepatol. 2019 Apr;70(4):796-797. doi: 10.1016/j.jhep.2018.11.031. Epub 2019 Jan 8. | 2019 |
Jun T, Hsu YC, Ogawa S, Huang YT, Yeh ML, Tseng CH, Huang CF, Tai CM, Dai CY, Huang JF, Chuang WL, Yu ML, Tanaka Y, Nguyen MH. | Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection. | Hepatol Commun. 2019 Feb 8;3(4):493-503. doi: 10.1002/hep4.1321. eCollection 2019 Apr. | 2019 |
Hsu YC, Wong GL, Chen CH, et al. | Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B. | Am J Gastroenterol. 2020;115(2):271–280. doi:10.14309/ajg.0000000000000428 | 2019 |
Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, et al. | Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. | Hepatol Int. 2019 Sep;13(5):587-598. doi: 10.1007/s12072-019-09974-z. Epub 2019 Aug 28. | 2019 |
Yao-Chun Hsu, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Chun-Ying Wu. | Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues". | J Hepatol. 2019;70(4):796–797. doi:10.1016/j.jhep.2018.11.031 | 2019 |
Feng-Chen Kao, Yu-Huan Hsueh, Yao-Chun Hsu, Pao-Hsin Liu6, Jung-Ting Wang, Yuan-Kun Tu | Low extremity amputation rate and high 10-year mortality rate after spinal cord injury in Taiwan: a population-based longitudinal study. | E-Da Medical Journal. 2019;6( 3):1-9. | 2019 |
Ching-Huang Su, Chian-Heng Su, Chi-Feng Hsieh, Yao-Chun Hsu, Ching-Chung Tsai, Yu-Cheng Tsai, Yu-Tsun Su. | Increased prevalence of atopic dermatitis in young children born from 2000 to 2009 in Taiwan: A nationwide population-based study. | E-Da Med J. 2019;6(4):1-7. | 2019 |
Kao FC, Hsu YC, Liu PH, Tu YK, Jou IM. | High 2-year mortality and recurrent infection rates after surgical treatment for primary septic arthritis of the hip in adult patients: An observational study. | Medicine (Baltimore). 2019 Aug;98(32):e16765 | 2019 |
Kao FC, Hsu YC, Wang CB, Tu YK, Liu PH. | Short-term and long-term revision rates after lumbar spine discectomy versus laminectomy: a population-based cohort study. | BMJ Open. 2018 Jul 17;8(7):e021028. doi: 10.1136/bmjopen-2017-021028. | 2018 |
Yao-Chun Hsu, Hsiu-J Ho, Teng-Yu Lee, Yen-Tsung Huang, Ming-Shiang Wu, Jaw-Town Lin, Chun-Ying Wu, Hashem B El-Serag. | Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. | J Viral Hepat. 2018;25(5):543–551. doi:10.1111/jvh.12832 | 2018 |
Wei YF, Chen JY, Lee HS, Wu JT, Hsu CK, Hsu YC. | Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study. | BMJ Open. 2018 Jan 24;8(1):e019661. doi: 10.1136/bmjopen-2017-019661. | 2018 |
Hsu YC, Cheuk-Fung Yip T, Ho HJ, Wai-Sun Wong V, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Lai-Hung Wong G, Wu CY. | Development of a scoring system to Predict Hepatocellular Carcinoma in Asians on Antivirals for Chronic Hepatitis B. | J Hepatol. 2018;69(2):278–285. doi:10.1016/j.jhep.2018.02.032. [published correction appears in J Hepatol. 2019 Mar;70(3):581]. | 2018 |
Lin IC, Lee CT, Hsu YC, Tseng CM. | An unusual cause of upper gastrointestinal bleeding. | Dig Liver Dis. 2018 Jan;50(1):92. doi: 10.1016/j.dld.2017.07.009. Epub 2017 Jul 29.0 | 2018 |
Yu-Tsun Su, Ying-Chun Li, Li-Min Chen, Ching-Chung Tsai, Yuan-Yi Huang, Chen-Kuang Niu, Hong-Ren Yu, Chao-Yu Chuang, Yao-Chun Hsu, Jiu-Yao Wang, Ming-Chun Yang, Yu-Cheng Tsai | Asthma Phenotypes in the First Three Years of Life and Correlation with Active Asthma at Six Years of Age: A National Population-Based Study in Taiwan | E-Da Med J 2018;5(2):9-19. | 2018 |
Lai ZL, Tseng CH, Ho HJ, Cheung CKY, Lin JY, Chen YJ, Cheng FC, Hsu YC, Lin JT, El-Omar EM, Wu CY. | Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice. | Sci Rep. 2018 Oct 23;8(1):15625. doi: 10.1038/s41598-018-33893-y. | 2018 |
Cheng-Hao Tseng, Chi-Yang Chang, Lein-Ray Mo, Jaw-Town Lin, Chi-Ming Tai, Daw-Shyong Perng, Chih-Wen Lin, Yao-Chun Hsu | Acoustic Radiation Force Impulse Elastography With APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients. | Ann Hepatol. 2018;17(5):789–794. doi:10.5604/01.3001.0012.3137 | 2018 |
Feng-Chen Kao, Yao-Chun Hsu, Pao-Hsin Liu, Yuan-Kun Tu | Magnetic Resonance Imaging is Useful for Diagnosis of Sacral Insufficiency Fracture and Target Identification in Sacroplasty | E-Da Med J 2018;5(4):21-30. | 2018 |
Hsu YC, Jun T, Huang YT, Yeh ML, Lee CL, Ogawa S, Cho SH, Lin JT, Yu ML, Nguyen MH, Tanaka Y. | Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B. | Aliment Pharmacol Ther. 2018;48(10):1128–1137. doi:10.1111/apt.15006 | 2018 |
Kao FC, Hsu YC, Lai PY, Wang CB, Tu YK, Chen WK. | One-year mortality and Periprosthetic infection rates after Total knee Arthroplasty in Cancer patients: a population-based cohort study. | BMC Cancer. 2018 Jun 4;18(1):628. doi: 10.1186/s12885-018-4329-2. | 2018 |
Hsu YC, Wei MT, Nguyen MH. | Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. | Expert Rev Gastroenterol Hepatol. 2017 Oct 8:1-10. doi: 10.1080/17474124.2017.1386554. [Epub ahead of print] | 2017 |
Kao FC, Hsu YC, Lin CJ, Lo YY, Tu YK. | Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy. | PLoS One. 2017 Jan 26;12(1):e0169468. doi: 10.1371/journal.pone.0169468. eCollection 2017. | 2017 |
Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT. | Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. | J Gastroenterol Hepatol. 2017 Aug;32(8):1512-1519. doi: 10.1111/jgh.13728. | 2017 |
Lee TY, Hsu YC, Yu SH, Lin JT, Wu MS, Wu CY. | Effect of Nucleos(t)ide Analogue Therapy on Risk of Intra-hepatic Cholangioarcinoma in Patients With Chronic Hepatitis B. | Clin Gastroenterol Hepatol. 2017 Sep 22. pii: S1542-3565(17)31166-7. doi: 10.1016/j.cgh.2017.09.031. [Epub ahead of print] | 2017 |
Kao FC, Hsu YC, Liu PH, Yeh LR, Wang JT, Tu YK. | Osteoporotic sacral insufficiency fracture: An easily neglected disease in elderly patients. | Medicine (Baltimore). 2017 Dec;96(51):e9100. doi: 10.1097/MD.0000000000009100. | 2017 |
Kao FC, Hsu YC, Chen WH, Lin JN, Lo YY, Tu YK. | Prosthetic Joint Infection Following Invasive Dental Procedures and Antibiotic Prophylaxis in Patients With Hip or Knee Arthroplasty. | Infect Control Hosp Epidemiol. 2017 Feb;38(2):154-161. doi: 10.1017/ice.2016.248. Epub 2016 Nov 9. | 2017 |
Tseng CM, Huang SP, Liao WC, Chiang CJ, Yang YW, Chang CY, Hsu YC, Chen HC, Chiang HS, Lin JT. | Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999-2012. | Cancer Epidemiol. 2017 Jun 7;49:75-84. doi: 10.1016/j.canep.2017.05.011. [Epub ahead of print] | 2017 |
Liou JM, Fang YJ, Chen CC, et al. | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. | Lancet. 2016 Oct 18. pii: S0140-6736(16)31409-X. doi: 10.1016/S0140-6736(16)31409-X. [Epub ahead of print] | 2016 |
Wu CY, Hsu YC, Ho HJ, Chen YJ, Lee TY, Lin JT. | Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. | Gut. 2016 Apr;65(4):693-701. doi: 10.1136/gutjnl-2014-308786. Epub 2015 Feb 10. | 2016 |
Kao FC, Hsu YC, Yen CY, Lin CJ, Wu CH, Tu YK. | Revision and Survival Rates After Total Knee Arthroplasty in Individuals Aged 70 and Older. | J Am Geriatr Soc. 2016 Nov;64(11):e225-e227. doi: 10.1111/jgs.14456. Epub 2016 Sep 19. | 2016 |
Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM1, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY. | Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. | PLoS One. 2016 Dec 9;11(12):e0167815. doi: 10.1371/journal.pone.0167815. eCollection 2016. | 2016 |
Tseng CM, Chen TB2, Hsu YC, Chang CY, Lin JT, Mo LR. | Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy. | Asia Pac J Clin Oncol. 2016 Dec;12(4):421-429. doi: 10.1111/ajco.12520. Epub 2016 Jul 20. | 2016 |
Liou JM, Fang YJ, Chen CC, et al. | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. | Lancet. 2016 Nov 12;388(10058):2355-2365. doi: 10.1016/S0140-6736(16)31409-X. Epub 2016 Oct 18. | 2016 |
Hsu YC, Mo LR, Chang CY, Wu MS, Kao JH, Wang WL, Yang TH, Wang CS, Chiang MF, Chen CC, Fang YJ, Hung HW, Wu CY, Lin JT. | Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients. | Clin Gastroenterol Hepatol. 2016 Oct;14(10):1490-1498.e3. doi: 10.1016/j.cgh.2016.03.024. Epub 2016 Mar 24. | 2016 |
Tsai MS, Lin CL, Hsu YC, Lee HM, Kao CH. | Long-term risk of pancreatitis and diabetes after cholecystectomy in patients with cholelithiasis but no pancreatitis history: A 13-year follow-up study. | Eur J Intern Med. 2015 Sep;26(7):540-4. doi: 10.1016/j.ejim.2015.06.013. Epub 2015 Jul 2. | 2015 |
Fang YJ, Liou JM, Chen CC, Lee JY, Hsu YC, Chen MJ, Tseng PH, Chen CC, Chang CY, Yang TH, Chang WH, Wu JY, Wang HP, Luo JC, Lin JT, Shun CT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria. | Gut. 2015 Oct;64(10):1517-28. doi: 10.1136/gutjnl-2014-308114. Epub 2014 Nov 18. | 2015 |
Hsu YC, Lin HJ. | Intermittent bolus or continuous infusion of proton pump inhibitors for ulcer bleeding? | JAMA Intern Med. 2015 Mar 1;175(3):461. doi: 10.1001/jamainternmed.2014.7797. | 2015 |
Hsu YC, Ho HJ, Huang YT, Wang HH, Wu MS, Lin JT, Wu CY. | Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. | Gut. 2015 Mar;64(3):495-503. doi: 10.1136/gutjnl-2014-308163. Epub 2014 Nov 14. | 2015 |
Tsai MS, Hsu YC, Yu PC, Lin CL, Kao CH. | Long-term risk of acute coronary syndrome in hepatitis C virus infected patients without antiviral treatment: A cohort study from an endemic area. | Int J Cardiol. 2015 Feb 15;181:27-9. doi: 10.1016/j.ijcard.2014.11.200. Epub 2014 Nov 27. | 2015 |
Hsu YC, Wu CY, Lin JT. | Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma. | Semin Oncol. 2015 Apr;42(2):329-338. doi: 10.1053/j.seminoncol.2014.12.023. Epub 2014 Dec 31. | 2015 |
Hsu YC, Wu CY. | Reply: To PMID 25398770. | Gastroenterology. 2015 Aug;149(2):501-2. doi: 10.1053/j.gastro.2015.06.034. Epub 2015 Jun 29. | 2015 |
Wang WL, Wang YC, Lee CT, Chang CY, Lo JL, Kuo YH, Hsu YC, Mo LR. | The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers. | J Dig Dis. 2015 May;16(5):256-63. doi: 10.1111/1751-2980.12236. | 2015 |
Lo GH, Lin CW, Hsu YC. | A controlled trial of early versus delayed feeding following ligation in the control of acute esophageal variceal bleeding | J Chin Med Assoc. 2015 Nov;78(11):642-7. doi: 10.1016/j.jcma.2015.07.004. Epub 2015 Sep 2. | 2015 |
Liou JM, Chen CC, Chang CY, et al. | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial. | Gut. 2015 Sep 3. pii: gutjnl-2015-310142. doi: 10.1136/gutjnl-2015-310142. [Epub ahead of print] | 2015 |
Hsu YC, Lin HJ. | Intermittent bolus or continuous infusion of proton pump inhibitors for ulcer bleeding? | JAMA Intern Med. 2015 Mar;175(3):461. doi: 10.1001/jamainternmed.2014.7797. | 2015 |
Yao-Chun Hsu | Analyzing Taiwan's National Health Insurance Research Database to explicate the allocation of health-care resources | Advances in Digestive Medicine. 2015:2:41-43. | 2015 |
Tsai MS, Li YF, Lin CL, Hsu YC, Lee PH, Sung FC, Kao CH. | Long-term risk of acute coronary syndrome in patients with cholangitis: A 13-year nationwide cohort study. | Eur J Intern Med. 2014 Jun;25(5):444-8. doi: 10.1016/j.ejim.2014.03.015. Epub 2014 Apr 6. | 2014 |
Hsu YC, Lin JT, Ho HJ, Kao YH, Huang YT, Hsiao NW, Wu MS, Liu YY, Wu CY. | Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. | Hepatology. 2014 Apr;59(4):1293-302. doi: 10.1002/hep.26892. Epub 2014 Feb 18. | 2014 |
Liao F, Hsu YC, Kuo SH, Yang YC, Chen JP, Hsu PN, Lin CW, Chen LT, Cheng AL, Fann CS, Lin JT, Wu MS. | Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. | Blood Cancer J. 2014 Oct 10;4:eXX. doi: 10.1038/bcj.2014.70. | 2014 |
Fang YJ, Liou JM, Chen CC, Lee JY, Hsu YC, Chen MJ, Tseng PH, Chen CC, Chang CY, Yang TH, Chang WH, Wu JY, Wang HP, Luo JC, Lin JT, Shun CT, Wu MS; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria. | Gut. 2014 Nov 18. pii: gutjnl-2014-308114. doi: 10.1136/gutjnl-2014-308114. [Epub ahead of print] | 2014 |
Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR. | Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B. | J Antimicrob Chemother. 2014 Jul;69(7):1920-7. doi: 10.1093/jac/dku041. Epub 2014 Feb 26. | 2014 |
Hsu YC, Wu CY. | The association between postoperative antiviral treatment and recurrence of hepatitis C virus-related hepatocellular carcinoma. | Hepatology. 2013 Aug 19. doi: 10.1002/hep.26691. [Epub ahead of print] | 2013 |
Wu CY, Hsu YC. | Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence--reply. | JAMA. 2013 Feb 27;309(8):766-7. doi: 10.1001/jama.2013.574. | 2013 |
Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Helicobacter Consortium. | Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. | Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16. | 2013 |
Hsu YC, Ho HJ, Wu MS, Lin JT, Wu CY. | Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. | Hepatology. 2013 Feb 6. doi: 10.1002/hep.26300. [Epub ahead of print] | 2013 |
Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT. | Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. | JAMA. 2012 Nov 14;308(18):1906-14. | 2012 |
Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. | Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study. | Hepatology. 2012 Aug;56(2):698-705. doi: 10.1002/hep.25684. Epub 2012 Jul 6. | 2012 |
Hsu YC, Lin JT. | Images in clinical medicine. Intestinal infestation with Ancylostoma ceylanicum. | N Engl J Med. 2012 Mar 29;366(13):e20. | 2012 |
Hsu YC, Yang TH, Liou JM, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS. | Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer? | Dig Liver Dis. 2012 Mar;44(3):218-23. Epub 2011 Nov 23. | 2012 |
Hsu YC, Chiu HM, Liou JM, Chang CC, Lin JT, Liu HH, Wu MS. | Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia. | Cancer Causes Control. 2012 Feb;23(2):321-8. Epub 2011 Nov 29. | 2012 |
Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT. | Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation. | Antivir Ther. 2012;17(4):605-12. doi: 10.3851/IMP2027. Epub 2011 Dec 20. | 2012 |
Hsu YC, Chung CS, Wang HP. | Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. | Int J Hepatol. 2011;2011:893973. Epub 2011 Jul 21. | 2011 |
Hsu YC, Liou JM, Yang TH, Hsu WL, Lin HJ, Wu HT, Lin JT, Wang HP, Wu MS. | Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? | J Gastroenterol. 2011 Feb;46(2):183-90. Epub 2010 Oct 19. | 2011 |